Dialog Box


Parkinson’s Victoria would like to thank our wonderful sponsors for their support of the inaugural 27forParkinson’s Virtual Event.


AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. Our heritage in Australia reaches back more than 80 years and we employ more than 450 people with our therapies currently benefiting more than 40,000 Australians. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments. Recently, we acquired Allergan which immediately diversified our business across several therapeutic areas: Immunology, Oncology, Virology, Neuroscience and Aesthetics.

Our commitment to making a remarkable impact doesn’t end at developing medicines; it begins there. We provide broader support to our patients and help address the health needs of underserved communities. We strive to protect our environment and to make a positive impact in the areas where we live and work.

For further information please visit www.abbvie.com.au. Follow  @AbbVie_AU on Twitter, Facebook , Instagram or our LinkedIn page.


Global Kinetics Pty Ltd (GK), a novel digital health company, is revolutionising the management of Parkinson’s disease by providing the first continuous and objective measurement of patients’ sympt­­oms in everyday environments. The company’s Personal KinetiGraph® (PKG®) is a patient-friendly, algorithm-based system that records patients’ movements over the course of several days and creates data-driven reports that empowers more personalised treatment and management decisions—ultimately leading to a higher quality of life for patients. For further information visit www.globalkineticscorp.com.au


UCB aspires to be the patient-centric global biopharmaceutical leader, transforming the lives of people with severe diseases.

At UCB our sense of purpose is to help people suffering from severe central nervous system disorders lead normal, everyday lives. Our ambition is to offer them innovative new medicines and ground-breaking solutions that go beyond the drug. We are committed to enabling cutting-edge scientific research that is driven by patients’ needs. https://ucbaustralia.com.au/


Making healthcare better is our priority and we believe technology can play an even greater role in improving people’s lives. In addition to alleviating pain, restoring health, extending lives, we work in partnership with others to create seamless, more efficient care. Learn how we’re taking healthcare Further, Together at www.medtronic.com.


STADA Australia is a speciality pharmaceutical company focusing on infusion therapies in neurology in Australia and New Zealand. We are part of a global pharmaceutical group of companies founded 125 years ago with offices in more than 30 countries, selling high-quality, innovative pharmaceutical products in approximately 120 countries.

We at STADA Australia are dedicated to the supply of innovative products for chronic and serious medical conditions, especially the treatment of Parkinson’s disease. 

At STADA, we fully understand the importance of partnering with healthcare professionals in improving the quality of life of Parkinson’s disease patients and supporting carers through the provision of specialty products and services. www.stada.com.au